Associations between metabolic score for visceral fat and the risk of cardiovascular disease and all-cause mortality among populations with different glucose tolerance statuses
Authors' conclusion
The METS-VF was associated with an increased risk of CVD events and all-cause mortality and could be used as a predictive index of the risk of CVD events and all-cause mortality among populations with different glucose tolerance statuses.
Study context
- Population
- Participants aged ≥40 years with different glucose tolerance statuses (normal glucose tolerance, prediabetes, diabetes)
- Participants
- 6,827 participants
- Exposure
- Metabolic score for visceral fat (METS-VF) quartile 4 vs quartile 1
- Outcome
- CVD events and all-cause mortality
- Follow-up
- 5.00 years
Main finding
As reported in the abstract
CVD events, by glucose tolerance status · 5.00 years
Quartile 4 vs Quartile 1Adjusted hazard ratio (95% CI)
Normal glucose tolerance
5.75(2.67–12.42)
Prediabetes
2.80(1.76–4.48)
Diabetes
3.31(1.28–8.54)
- Cardiovascular disease (CVD) events
- 338
Observational data: associations, not effects.
Further findings
| Outcome | aHR (95% CI) | |
|---|---|---|
| All-cause mortality, by glucose tolerance status · 5.00 yearsQuartile 4vs Quartile 1Normal glucose tolerance | 2.80 (1.43–5.49) | |
| All-cause mortality, by glucose tolerance status · 5.00 yearsQuartile 4vs Quartile 1Prediabetes | 4.15 (2.45–7.01) | |
| All-cause mortality, by glucose tolerance status · 5.00 yearsQuartile 4vs Quartile 1Diabetes | 4.03 (1.72–9.42) | |
| 0.10.31310Adjusted hazard ratio (log scale) |
- All-cause mortality, by glucose tolerance status — All-cause deaths
- 307
Dose-response and prediction
- Restricted cubic spline suggested a dose-response association of METS-VF with CVD events and all-cause mortality
- AUC for CVD events and all-cause mortality higher for METS-VF than for other obesity and IR indexes in all glucose tolerance statuses
Original publication
Associations between metabolic score for visceral fat and the risk of cardiovascular disease and all-cause mortality among populations with different glucose tolerance statuses. Diabetes Res Clin Pract. Published 24 July 2023. doi:10. 1016/ j. diabres. 2023. 110842
Composed by AI from the published abstract and checked against it. How Briefs are made →